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1. Introduction
  Malaria has always been a major killer of populations 
throughout the tropics for thousands of years. Despite 
important advances in our understanding of the disease, it 
continues to be one of the greatest causes of serious illness 
and death in the world.  Over 75% of 2-3 million deaths 
occurring in African children, and about 500 million new 
cases reported annually is a challenge to drug therapy and 
discovery. Of the four species of human malarial parasite, 
Plasmodium falciparum (P. falciparum) is remarkable 
for its high fatality particularly among young children 
and alarming development of resistance to antimalarial 
drugs. Resistance to antimalarials is spreading throughout 
the world and is impeding efforts to malaria control[1]. 
Resistance of P. falciparum to the most affordable drugs 
such as chloroquine and sulfadoxine/pyrimethamine and 
mefloquine has become widespread throughout Africa and 
Asia, in particular Southeast Asia[1].
  Malaria-infected erythrocytes are under oxidative stress 
produced by the digestion of host’s hemoglobin. The oxidant 
enzymes in glutathione (GSH) system, i.e, glutathione 
reductase (PfGR) and glutathione S-transferase (PfGST) 
are detected in malaria-infected cells[2-5]. Difference in 
the levels of these enzymes were shown in P. falciparum 
isolates with different sensitivity to chloroquine[4, 6-7].  This 
may imply the importance of these enzymes in survival 
Objective: To investigate the association between amplification of the two regulatory genes 
controlling glutathione (GSH) levels, glutathione reductase (PfGR) and glutathione S-transferase 
(PfGST) genes and sensitivity of Plasmodium falciparum (P. falciparum) isolates collected 
from different malaria endemic areas of Thailand to standard antimalarial drugs.  Methods: A 
total of 70 P. falciparum isolates were collected from endemic areas of multi-drug resistance 
(Tak, Chantaburi and Ranong Provinces) during the year 2008-2009. The in vitro assessment 
of antimalarial activity of P. falciparum clones (K1- and Dd2 chloroquine resistant and 3D7- 
chloroquine sensitive) and isolates to chloroquine, quinine, mefloquine and arteusnate was 
performed based on SYBR Green modified assay.  Results: 68 (97.14%), 11 (15.71%) and 28 (40%) 
isolates respectively were classified as chloroquine-, quinine- and mefloquine-resistant isolates. 
With this limited number of P. falciparum isolates included in the analysis, no significant 
association between amplification of PfGST gene and sensitivity of the parasite to chloroquine, 
quinine, mefloquine and quinine was found.  Based on PCR analysis, Dd2, K1 and 3D7 clones all 
contained only one copy of the PfGST gene. All isolates (70) also carried only one copy number 
of PfGST gene. There appears to be an association between amplification of PfGR gene and 
chloroquine resistance. The 3D7 and Dd2 clones were found to carry only one PfGR gene copy, 
whereas the K1 clone carried two gene copies. Conclusions: Chloroquine resistance is likely 
to be a consequence of multi-factors and enzymes in the GSH system may be partly involved. 
Larger number of parasite isolates are required to increase power of the hypothesis testing in 
order to confirm the involvement of both genes as well as other genes implicated in glutathione 
metabolism in conferring chloroquine resistance.
Raewadee Wisedpanichkij et al./Asian Pacific Journal of Tropical Medicine (2010)673-677674
of malaria parasites, including their possible involvement 
in conferring antimalarial drug resistance. Any compound 
inhibiting these molecules would eventually lead to parasite 
death, and thus be a promising antimalarial drug candidate. 
The objective of the study was to investigate the association 
between amplification of PfGR and PfGST genes and 
sensitivity of P. falciparum isolates collected from different 
malaria endemic areas of Thailand that were resistant 
to standard antimalarial drugs chloroquine, quinine, 
mefloquine and artesunate.  
2. Materials and methods
2.1. Parasite cultivation 
  A total of 70 P. falciparum isolates were collected from 
endemic areas of multidrug resistance (Tak, Chantaburi 
and Ranong Provinces) during the year 2008-2009. Prior 
to the study, approval of the study protocol was obtained 
from the Ethics Committee of the Ministry of Public Health, 
Thailand. Written informed consent for study participation 
was obtained from all patients prior to blood sample 
collection. K1 and Dd2 (chloroquine-resistant reference 
clones) and 3D7 (chloroquine-sensitive reference clone) 
P. falciparum clones including all isolates were cultured 
in RPMI 1640 medium (Gibco, USA) supplemented with 
10% human B serum and 25 mM HEPES.  Cultures were 
maintained at 37 曟 under an atmosphere of 5% O2, 5% CO2, 
and 90% N2[8]. The level of parasitemia in the cultures was 
maintained between 2 and 10%, with 5% hematocrit. 
2.2. Preparation of drug solutions 
  Standard powder of tested antimalarial drugs, i.e., 
chloroquine, quinine, mefloquine and artesunate were 
prepared in 50% ethanol at the concentration of 10 nM. 
On the day of experiment, stock solutions were diluted 
with serum-free medium in order to obtain required 
concentrations (1 000, 4 000, 400 and 100 nM for chloroquine, 
quinine, mefloquine and artesunate, respectively). 
2.3. In vitro antimalarial sensitivity test  
            
  The in vitro assessment of antimalarial activity of P. 
falciparum clones and isolates to chloroquine, quinine, 
mefloquine and artesunate was performed based on SYBR 
Green fluorescence-based assay[9]. Experiment was done 
in triplicate for each isolate/clone. Parasites used in all 
experiments were synchronized to the ring stage according 
to the method of Lambros and Vanderburg using 5% (w/
v) sorbital[10]. For investigating antimalarial activity, an 
aliquot of parasite inoculum (10 毺L) with 1% parasitemia 
and 20% hematocrit was added into each well of microtiter 
plate. The test wells consisted of varying concentrations of 
each drug. All experiments were performed in triplicate. 
The microtiter plates were placed in a candle jar with 
atmosphere consisting of 3% O2, 90% NO2 and 7% CO2. 
Following a 48 hr incubation period, the plates were removed 
from the incubation box and 100 毺L of the fluorescent 
hemolysis reagent was added to each well. The plates were 
then incubated at 37 曟 for an additional 1 h for optimal 
development of fluorescent dye. Fluorescent intensity was 
then read by Varioskan Flash Machine (Thermo Electron 
Incorporation, USA) at the excitation and emission wave 
lengths of 485 and 530 nm. 
  The percent growth was compared between numbers of 
schizont in each drug-containing well and the control well. 
Concentration-response analysis was performed using 
GrafitTM (Erithacus Software Ltd., U.K) in order to obtain 
fifty percent inhibitory concentration (IC50) values. 
  Threshold IC50 values for chloroquine, quinine, and 
mefloquine were 25 500 and 24 nM, respectively[11-12]. For 
artesunate, there is currently no defined threshold IC50 
value.
2.4. Analysis of the amplification of PfGST and PfGR genes 
of P. falciparum isolates
 
  Analysis of the copy numbers of the two regulatory gene 
controlling glutathione levels, PfGST and PfGR was performed 
and used as template to design primers for investigating 
copy numbers of these genes in all P. falciparum isolates 
and the reference clones. DNA of P. falciparum isolates was 
extracted from in vitro culture by chelex-resin modified 
technique[13]. 
  Allele-specific oligonucleotides from the genes encoding 
PfGR and PfGST were selected according to the report of 
Ferreira and colleagues[14], using Pf毬-actin as house 
keeping gene control. The forward and reverse primers for 
PfGST, PfGR and 毬-actin genes were as follows: 
  PfGR: 5’-GCA GTG GCC TTA AAA ATG AAT G-3’ and 5’-GCT 
GTA GGA TGT ATA GGT ATG G-3’. The target fragment is 68 
bp.
  PfGST: 5’-GAT GCA AGG GGT AAA GCT G-3’ and 5’-GGG 
TAC TTG CTC AAA AGG AG-3’. The target fragment is 150 bp.
Pf毬-actin: 5’-GGA CAC ATA TTG TGC CTG C-3’ and 5’-CTC CAC 
TAT CTA ACA CAA TAC C-3’. The target fragment is 90 bp.
  Real-time quantitative PCR was performed in DNA 
extracted from all parasite isolates using Platinum 
SYBRTM Green qPCR Supermix-UDG (Invitrogen, USA) and 
amplification of the copy numbers of PfGR, PfGST and 毬
-actin genes was performed in the iCycler IQ (Bio-Rad, USA) 
using the default thermocycler program for all genes: 10 min 
of pre-incubation at 95 曟, followed by 40 cycles for 15 sec 
at 95  曟, and 1 min at 58  曟. Individual real-time PCR 
reaction was carried out in 25 毺L volume of the mixture 
of Platinum SYBRTM Green qPCR Supermix-UDG containing 
1x buffer (10x), 3.5 mM MgCl2, 200 毺M dNTPs, 0.025 U/毺L 
PlatinumTM Taq DNA polymearse enzyme and 1:66000 SYBR 
GreenTM, 1 毺M of sense and antisense primers, and DNA 
template (3 毺L) in a 96-well plate (Genuine Axygen 
Quality, USA). At the end of each reaction, cycle threshold 
(Ct) was manually set up at the level that reflected the best 
kinetic PCR parameters and melting curves were acquired 
and analyzed. The 2-ΔΔCt method of relative quantification 
was adapted to estimate copy numbers of PfGR and PfGST 
in P. falciparum genes[14].  Genomic DNA extracted from P. 
falciparum 3D7, known to harbor a single copy of PfGR and 
PfGST, was used as calibrator, while Pf-毬-actin served as 
the house-keeping gene in all real-time PCR experiments. 
TheΔΔCt calculation for the relative quantification of 
target was used as follow: ΔΔCt = (Ct, target gene - Ct, Pf-毬
-actin)χ- (Ct, target gene-Ct, Pf-毬-actin)y, where χ 
= unknown sample and y = P. falciparum 3D7). Result for 
each sample was expressed as N-fold changes in χ target 
gene copies, normalized to Pf-毬-actin relative to the copy 
number of the target gene in P. falciparum 3D7, according 
Raewadee Wisedpanichkij et al./Asian Pacific Journal of Tropical Medicine (2010)673-677 675
to the following equation: amount of target = 2-ΔΔCt[14-
15].  In each experiment, each individual sample was run in 
duplicate wells and the Ct of each well was recorded at the 
end of the reaction. Result for each sample was expressed 
as the N-fold copy number of a given gene relative to P. 
falciparum 3D7. Assay was repeated if amplification curve 
did not reflect exponential kinetic parameters or if the 
N-fold copy number of a given gene was lower than 0.7 or 
higher than 1.3. In case where N-fold was comprehended 
between those values (0.7 <N-fold< 1.3), it was accepted 
that the test sample harbored a single copy of the target gene 
(N-fold = 1).
2.5. Statistical analysis
  Non-parametric statistics were applied for analysis of data 
which were not normally distributed. Quantitative data were 
presented as median (range) values, whereas qualitative 
data were presented as number (%) values. The analysis 
of the association between genetic polymorphisms (gene 
amplification) of PfGR and PfGST and sensitivity of P. falciparum 
isolates to the tested antimalarials was performed using Chi-square 
test at a statistical significance level of 毩 = 0.5.  
3. Results
3.1. Assessment of antimalarial drug sensitivity
  Median (range) IC50 values of the 70 P. falciparum isolates 
for chloroquine, quinine, mefloquine and artesunate were 
67.68 (9.4-189.86), 239.12 (35.10-870.80), 29.33 (3.4-105.44) and 
1.91 (0.77-5.77) nM, respectively (Table 1). Median IC50 values 
of chloroquine, quinine, mefloquine and artesunate for the 
K1 clone were 128.68, 376.27, 10.43 and 1.91 nM, respectively. 
The corresponding median IC50 values for the 3D7 clone were 
9.40, 58.57, 20.82 and 2.14 nM, respectively.   Representative 
plots of concentration response curves for chloroquine, 
quinine, mefloquine and artesunate are shown in Figure 
1. IC50 values for chloroquine, quinine and mefloquine 
were categorized based on the sensitivity level to sensitive 
and resistant groups.  Sixty-eight isolates (97.14%) were 
classified as chloroquine-resistant isolates with median 
(range) IC50 value of 68.14 (26.33-189.86) nM; only 2 isolates 
(2.86%) were classified as chloroquine-sensitive isolates 
with median (range) IC50 value of 16.77 (9.40-24.14) nM. For 
quinine, 59 isolates (84.29%) were classified as quinine-
sensitive isolates with median (range) IC50 value of 220.55 
(35.10-494.60) nM; 11 isolates (15.71%) were classified as 
quinine-resistant isolates with median (range) IC50 value of 
667.08 (501.49-870.80) nM. For mefloquine, 42 isolates (60.0%) 
were classified as mefloquine-sensitive isolates with median 
IC50 (range) value of 46.54 (24.33-105.44) nM; 28 isolates 
(40.0%) were classified as mefloquine-resistant isolates with 
median (range) IC50 value of 13.92 (3.40-22.63) nM. 
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Figure 1.  Representative plots of concentration response curves and 
IC50 values for chloroquine (CQ: A, B), quinine (QN: C, D), mefloquine 
(MQ: E, F) and artesunate (ARS: G, H) in sensitive and resistant 
isolates.
3.2. Association between amplification of PfGST and PfGR 
and sensitivity of P. falciparum isolates to antimalarial drugs
  Based on PCR analysis, Dd2, K1 and 3D7 clones all 
contained only one copy of the PfGST gene. All isolates 
(n=70) also carried only one copy number of PfGST gene. 
For PfGR however, the 3D7 and Dd2 clones were found to 
carry only one gene copy, whereas the K1 clone carried two 
gene copies. Two isolates collected from Tak (Mae-Sot) 
and Ranong Provinces carried two PfGR gene copies. The 
median IC50 values (from three experiments) of chloroquine, 
quinine, mefloquine and artesunate for these two isolates 
were 68.94 vs 109.38, 98.95 vs 258.12, 29.98 vs 17.31, and 0.93 
vs 2.19 nM, respectively. 
Table 1
Number (%) and median (range) IC50 values of chloroquine, quinine and mefloquine in P. falciparum isolates classified in sensitive and resistant 
groups.
Drug
Drug sensitivity test (n=70)
Sensitive group Resistant group
Number (%) Median (range) IC50   (nM) Number (%) Median (range) IC50   (nM)
Chloroquine  2 (2.86) 16.77(9.40-24.14) 68 (97.14) 68.14(26.33-189.86)
Quinine 59 (84.29)  220.55(35.10-494.60) 11 (15.71) 667.08(501.49-870.80)
Mefloquine 28 (40.00) 13.92(3.40-22.63) 42 (60.00) 46.54(24.33-105.44)
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4. Discussion
  In vitro sensitivity test for a total of 70 isolates collected 
from malaria endemic areas of multi-drug resistance 
(Tak and Ranong Provinces) during the year 2008-2009 
was performed based on SYBR Green fluorescence-based 
assay[16].  This fluorescence-based assay is sensitive, 
accurate, reliable, and less expensive than radio-isotopic[17] 
and colorimetric-based histidine-rich protein 2 capture 
ELISA[18] methods and involves only one-step in one plate 
to obtain results. Due to the fact that mature erythrocytes 
lack RNA and DNA, binding of the dye is specific for 
malarial DNA in any erythrocytic stage of P. falciparum 
development[16].  
  Median (range) IC50 values of chloroquine, quinine, 
mefloquine and artesunate in a total of 70 P. falciparum 
isolates were 67.65 (9.4-189.86), 237.04 (35.10-870.80), 
29.48 (3.4-105.44) and 1.90 (0.77-5.77) nM, respectively. 
Threshold IC50 values of 25, 500, and 24 nM were used to 
classify resistance to chloroquine, quinine and mefloquine, 
respectively. The sensitivity of P. falciparum isolates in 
Mae-Sot area to chloroquine and quinine appears to be 
gradually increased when compared with data published 
during the year 1991-1992[geometric mean (range) IC50: 
193.23 (148.24-251.85) nM], 1994[geometric mean (range) 
IC50: 157.05 (124.11-198.73) nM], and 2003[geometric mean 
(range) IC50: 120.50 (105.75-137.32) nM][19-20].  Nevertheless, 
chloroquine resistance has still remained in this area since 
67 isolates (97.1%) were indentified as chloroquine-resistant 
isolates, whereas only 2 isolates (2.9%) were identified as 
chloroquine-sensitive isolates.  The geometric mean (range) 
IC50 values of quinine during the years 1991-1992, 1994 and 
2003 were 576.22 (460.51-720.99), 403.87 (330.650-493.54) 
and 382.34 (312.88-467.22) nM, respectively[19-20]. About 
15.94% (11 isolates) were defined as quinine-resistant. For 
mefloquine however, sensitivity level seems to be improved, 
but the prevalence of mefloquine-resistant isolates was 
relatively high (60.8%). Mefloquine sensitivity was declined 
in 1994[geometric mean (range) IC50: 95.48 (75.90-120.12) nM] 
and 2003[geometric mean (range) IC50: 98.79 (79.72-122.42) 
nM] from that in 1991-1992[geometric mean (range) IC50: 
67.71 (46.77-96.48) nM][19-20], but was markedly improved 
during the year 2008-2009.  Sensitivity to artesunate was 
more or less stable with IC50 values varying in the narrow 
range of 0.77-5.77 nM during the year 1991-2009. Although 
the in vitro results obtained from various studies using 
different methods may not be directly compared, results 
reported using both the radio-isotopic and colorimetric-
based histidine-rich protein 2 capture ELISA methods[19-20] 
have been evaluated to provide comparable results with the 
fluorescence-based method used in the present study[21-22].
  GSH appears to be relevant in heme detoxification. 
Chloroquine and amodiaquine inhibit GSH-mediated 
heme degradation. Involvement of the two GSH associated 
enzymes, i.e., PfGST and PfGR has been implicated in P. 
falciparum drug resistance. PfGST is responsible for fighting 
reactive oxygen species and reduction of oxidative stress. 
Although the role of PfGST in drug detoxification process in 
P. falciparum is still unclear, several publications strongly 
support the hypothesis that the chloroquine-resistant 
mechanism in P. falciparum may involve an increase 
in PfGST enzyme activity[24-26]. Kavishe and colleagues 
suggested that PfGST polymorphisms could change the 
enzyme activity, leading to reduced detoxification of the 
host cell or increased availability of host GSH that might 
be used by the parasite[27]. There has been limited data on 
the amplification of PfGST gene in P. falciparum isolates in 
different malaria endemic areas.  Based on results obtained 
from the present study, no association between sensitivity 
of P. falciparum isolates to the four antimalarials and 
amplification of PfGST gene was observed. No amplification 
of PfGST gene was observed in any isolate; all carried only 
one gene copy. 
  PfGR plays a key role in cellular redox homeostasis 
catalyzing the reduction of GSSG to GSH and creates 
an intracellular GSH/GSSG ratio[28]. PfGR is an enzyme 
that is believed to have a significant role in malarial 
infection. Since the malarial parasite P. falciparum is 
known to be sensitive to oxidative stress, and thus the 
antioxidant enzyme PfGR has become an attractive drug 
target for antimalarial drug development[29]. Nowadays, 
functional P. falciparum glutathione was correlated to 
human glutathione[30]. Comparing to human glutathione, 
the PfGR has similar molecular functions as glutathione 
disulfide reductase activity, oxidoreductase activity, 
disulfide oxidoreductase activity and metal ion binding. 
In the present study, 3D7 and Dd2 P. falciparum clones 
(chloroquine-sensitive clones) were found to carry only 
one PfGR gene copy, while K1 (chloroquine-resistant clone) 
contained two gene copies. Only two isolates (collected from 
Tak and Ranong Provinces) were found to carry two copies 
of PfGR gene. The in vitro sensitivity results revealed that 
apart from K1 chloroquine-resistant clone, both isolates 
(out of 68 chloroquine-resistant isolates) which carried two 
copies of PfGR were classified as chloroquine-resistant. The 
present findings with PfGST support the finding of Ferreira 
and colleagues who demonstrated that both chloroquine-
sensitive (3D7) and chloroquine-resistant (Dd2) P. falciparum 
clones contain only one copy of this gene. However, result of 
the association with PfGR gene was not in agreement since 
no isolate (a total of 8 isolates collected from the Democratic 
Republic of Sao Tomé and Principe (DRSTP, the islands in 
Western Central Africa) with double gene copies was found 
in that study[14]. Difference of endemic areas of sample 
collection and number of isolates should be the reason of 
this disagreement. 
  In conclusion, with this limited number of P. falciparum 
isolates included in the analysis, no significant association 
between amplification of PfGST gene and sensitivity of the 
parasite to chloroquine, quinine, mefloquine and quinine 
was found. There appears to be the association between 
amplification of PfGR gene and chloroquine resistance. 
Chloroquine resistance is likely to be a consequence of 
multi-factors and enzymes in the GSH system may be partly 
involved. Larger number of parasite isolates are required to 
increase power of the hypothesis testing in order to confirm 
the involvement of both genes in conferring chloroquine 
resistance. Analysis of other elements implicated in 
glutathione metabolism, i.e., 毭-glutamyl-cysteinyl 
synthase, glutathione synthase, and glutathione transporter 
(MRP) should also be included in conjunction with the levels 
of reduced and oxidized glutathione. 
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